Albius Human Health

We have multiple pipelines of novel drug R&D and cosmetics.

Coronavirus

  • Hit compounds showing anti-viral effect against various strains of CoV (both animal and human), including MERS-CoV, Bat-CoV and SADS-CoV.

  • Identified prospect Pan-Anti-CoV candidates.

R&D for Infectious Diseases

Respiratory Syncytial Virus (RSV)

  • Lead compounds undergoing In Vivo Testings.

  • We have partnered with the world’s leading nano-encapsulation expert to co-develop the first-in-class medicine delivery system.

R&D for Hard-to-Treat Non-Infectious Diseases

Idiopathic Pulmonary Fibrosis (IPF)

  • Lead compounds undergoing In Vivo Testings.

  • We have partnered with the world’s leading nano-encapsulation expert to co-develop the first-in-class medicine delivery system.

In Early Drug Discovery Stage:

  • Senolytics

  • Endometriosis

  • Skin Fibrosis

  • Dengue